- Published at
- by gurufocus.com
positive
positive
Medexus Pharmaceuticals Inc (MEDXF) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Developments
Revenue: $30 million for fiscal Q3 2025, up from $25.2 million in the same period last year.Adjusted EBITDA: $5.8 million, an increase from $3.2 million in the